NanoViricides, Inc.

2.17 USD
-0.26 (-10.70%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NanoViricides, Inc. stock is up 80.83% since 30 days ago. The next earnings date is Oct 11, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.63% of the previous 18 May’s closed higher than April. 100% of analysts rate it a buy.

About NanoViricides, Inc.

NanoViricides, Inc. discovers, develops, and commercializes drugs for the treatment of viral infections. Company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction. Company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide.